- Home
- PHAT vs LINC Comparison
PHAT vs LINC Comparison
Compare PHAT & LINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- LINC
- Stock Information
- Founded
- PHAT 2018
- LINC 1946
- Country
- PHAT United States
- LINC United States
- Employees
- PHAT N/A
- LINC N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- LINC Other Consumer Services
- Sector
- PHAT Health Care
- LINC Real Estate
- Exchange
- PHAT Nasdaq
- LINC Nasdaq
- Market Cap
- PHAT 423.4M
- LINC 499.3M
- IPO Year
- PHAT 2019
- LINC 2005
- Fundamental
- Price
- PHAT $5.12
- LINC $16.16
- Analyst Decision
- PHAT Strong Buy
- LINC Strong Buy
- Analyst Count
- PHAT 4
- LINC 4
- Target Price
- PHAT $23.00
- LINC $20.25
- AVG Volume (30 Days)
- PHAT 1.5M
- LINC 181.7K
- Earning Date
- PHAT 03-06-2025
- LINC 05-05-2025
- Dividend Yield
- PHAT N/A
- LINC N/A
- EPS Growth
- PHAT N/A
- LINC N/A
- EPS
- PHAT N/A
- LINC 0.32
- Revenue
- PHAT $55,252,000.00
- LINC $440,064,000.00
- Revenue This Year
- PHAT $202.16
- LINC $9.85
- Revenue Next Year
- PHAT $113.86
- LINC $10.06
- P/E Ratio
- PHAT N/A
- LINC $50.63
- Revenue Growth
- PHAT 8001.47
- LINC 16.40
- 52 Week Low
- PHAT $4.07
- LINC $9.51
- 52 Week High
- PHAT $19.71
- LINC $19.79
- Technical
- Relative Strength Index (RSI)
- PHAT 41.95
- LINC 51.41
- Support Level
- PHAT $6.03
- LINC $15.25
- Resistance Level
- PHAT $6.89
- LINC $16.36
- Average True Range (ATR)
- PHAT 0.58
- LINC 0.68
- MACD
- PHAT 0.05
- LINC 0.11
- Stochastic Oscillator
- PHAT 37.23
- LINC 85.62
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About LINC Lincoln Educational Services Corporation
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services and business and information technology. Its reportable segments include; Campus Operations, and Transitional. Majority of the revenue is generated from Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.